VB

Vangala Bala Narsaiah Goud

Director Director DIN 01525426
DIN 01525426 First appointment Sep 2006 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Sep 2006
Shareholding value β€’β€’β€’β€’ Premium profile

About Vangala Bala Narsaiah Goud

Data last updated:

Vangala Bala Narsaiah Goud was a Director at Balaji Formulations Private Limited (2006–2010). The company operates in Pharma.

DIN 01525426
Primary Designation Director
Industry Pharma
First Appointment 12 Sep 2006

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Balaji Formulations Private Limited U24119TG2006PTC051112
Director12 Sep 20062006₹36.59 Cr (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Balaji Formulations Private Limited
Premium access

Shareholding and investment profile for Vangala Bala Narsaiah Goud

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vangala Bala Narsaiah Goud

Vangala Bala Narsaiah Goud was first appointed on 12 Sep 2006 as Director at Balaji Formulations Private Limited.

Vangala Bala Narsaiah Goud held 1 earlier board appointment: Balaji Formulations Private Limited (Director, 12 Sep 2006 to 05 Dec 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available